Radar · Genomics in Ile de France
Best Genomics Companies in Ile de France, France
The 71 best Genomics companies in Ile de France, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: DNA Script.
By Riya SenguptaFinancials
71companies tracked
$998.1Mdisclosed funding
0unicorns
38have raised
FLIAR INTELLIGENCE · GENOMICS × ILE DE FRANCE
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
84%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2016median founding year
181kcombined LinkedIn audience
33%of audience held by top 3
4companies hiring publicly (12 mo)
Ranked: Best Genomics companies in Ile de France
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | DNA Script Developer of benchtop DNA printer for nucleic acid synthesis | $315M | 33 mo ago | 202 | Xavier Godron Co-founder & CTO | WordPress Block EditorWordPressBugHerd+30 | 334 patents Enzymatic, template‑free nucleic acid synthesis and purification for custom DNA manufacturing | — |
| 2 | HiFiBiO Provider of a technology platform for the discovery of antibody-based drugs | $180M | 60 mo ago | 75 | Liang Schweizer Founder | — | 36 patents Ligand‑receptor pair identification and biosensor assay technologies for drug discovery | — |
| 3 | SparingVision Developer of drugs using gene therapy to treat retinitis pigmentosa | $128M | 45 mo ago | 41 | Jose Sahel Co-Founder | WordPress Block EditorwpBakeryWordPress+24 | 37 patents Ophthalmic gene/biologic therapies enhancing retinal neuron survival and light sensitivity | 1 award |
| 4 | GenSight Biologics Developer of viral vector-based gene therapies for retinal neurodegenerative diseases 55AI top 15%Product top 19%Funding top 20%Patents top 33% All 11 signals ▾AItop 15% Producttop 19% Fundingtop 20% Patentstop 33% Moattop 38% Innovationtop 43% Globaltop 47% Growthbottom 47% Marketbottom 41% Newsbottom 33% Techbottom 31% AI: Holds AI/ML patents (G06N-family CPC) Product: 3 distinct product lines · Company stage: Public rank vs industry peers · Fliar Intelligence Index 55/100 | $77M | 3 mo ago | 23 | — | WordPressMySQLPHP+12 | 89 patents Optogenetic gene‑therapy vectors and precision light‑delivery devices for retinal treatments | 1 award |
| 5 | Stilla Technologies Developer of digital PCR solution for research | $53M | 55 mo ago | 100 | Clement Gay Co-Founder | WordPress Block EditorWordPressMySQL+25 | — | — |
| 6 | Eligo Bioscience Developer of in vivo gene editing technology for microbiome modulation 48Patents top 16%Innovation top 19%Moat top 29%Funding top 36% All 11 signals ▾Patentstop 16% Innovationtop 19% Moattop 29% Fundingtop 36% Techtop 48% Talentbottom 49% Growthbottom 48% Globalbottom 44% Marketbottom 42% Fin. healthbottom 27% Newsbottom 22% Patents: 199 patents matched (strict assignee match) · 142 filings since 2022 vs 57 in 2017-21 Innovation: 199 patents (top 13% of patent-holders) · 142 filings since 2022 vs 57 in 2017-21 rank vs industry peers · Fliar Intelligence Index 48/100 | $52M | 13 mo ago | 44 | Xavier Duportet Co-Founder & CEO | WordPressVisual ComposerwpBakery+26 | 199 patents Phage‑based diagnostics and therapeutics targeting Cutibacterium acnes skin microbiome. | 1 job opening |
| 7 | Da Volterra Developer of products to prevent bacterial infections triggered by antibiotic therapies | $24M | 105 mo ago | 16 | — | — | 164 patents Engineered probiotic yeast and oral adsorbent formulations for gut‑targeted antibiotic resistance mitigation | — |
| 8 | Lysogene Developer of gene therapies for neurodegenerative lysosomal storage disorders | $23M | 75 mo ago | 22 | — | — | 16 patents AAV gene‑therapy vectors targeting lysosomal storage neurodegenerative diseases | — |
| 9 | DeepLife Provider of AI-based drug discovery and omics analysis tool for researchers 37AI top 22%Funding top 40%Moat top 45%Patents top 48% All 8 signals ▾AItop 22% Fundingtop 40% Moattop 45% Patentstop 48% Innovationtop 49% Talentbottom 49% Globalbottom 39% Marketbottom 24% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Funding: Raised $16.4M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 37/100 | $16M | 18 mo ago | 10 | Jonathan Baptista Co-Founder & CEO | — | 4 patents AI-driven graph analytics and generative digital twin simulation for complex system modeling | 1 award |
| 10 | IntegraGen Develops molecular diagnostic tests and genomic services. | $15M | 167 mo ago | 63 | Bernard Courtieu Chief Executive Officer | — | 199 patents Predictive biomarkers and in‑vitro assays for EGFR inhibitor response in cancer patients | — |
| 11 | Meiogenix Developer of novel breeding technologies for crop plants | $13M | 54 mo ago | 7 | Luc Mathis CEO | WebflowGSAPMicrosoft Advertising+10 | 39 patents CRISPR‑based tools for engineered meiotic recombination and genome editing | — |
| 12 | Rarecells Developer of noninvasive tests for earlier cancer diagnoses | $13M | 54 mo ago | 22 | — | — | 20 patents Rare cell isolation, filtration, and liquid biopsy biomarker analysis for cancer and blood disorder diagnostics | 1 partnership · 1 award |
| 13 | Annapurna Therapeutics Developer of adeno-associated virus (AAV) mediated gene therapies for rare diseases | $12M | 146 mo ago | — | Amber Salzman ex-CEO | — | — | — |
| 14 | WhiteLab Genomics Provider of drug discovery and development platform | $10M | 45 mo ago | 29 | David Del Bourgo CEO co-founder | SkolengoSentryApple iCloud Mail+20 | 4 patents ML-driven phenotype prediction and cell‑surface protein identification for functional genomics | — |
| 15 | PathoQuest Provider of next-generation sequencing for microbiology testing | $10M | 55 mo ago | 48 | — | WordPressMySQLPHP+29 | 68 patents Clinical diagnostics for microbial viability and anellovirus-based immune suppression biomarkers | — |
| 16 | Genomic Vision Nanotechnology for single DNA analysis for cancer and acute disease molecular diagnostics | $9M | 133 mo ago | 37 | Aaron Bensimon Founder & CEO | — | 108 patents Detecting viral DNA integration and telomere analysis using molecular combing technologies | — |
| 17 | Scipio Bioscience Develops sample preparation solutions | $8M | 36 mo ago | 44 | Pierre Walrafen Co-Founder & CEO | — | 19 patents Hydrogel-based spatial omics platforms for single-cell capture and barcoding | — |
| 18 | Biomemory Online platform offering bio-digital data storage solutions | $5M | 18 mo ago | 10 | Erfane Arwani Co-Founder & CEO | WebflowGSAPLenis+15 | — | — |
| 19 | One Biosciences Developer of single-cell therapeutics solutions to treat multiple health disorders | $5M | 11 mo ago | — | Celine Vallot Co-Founder | WordPressMySQLPHP+7 | — | 1 partnership · 2 awards |
| 20 | DNA Therapeutics Developer of DNA molecules for cancer therapy | $4M | 188 mo ago | 10 | — | — | 25 patents Patents concentrated in health & consumer products | — |
| 21 | Brink Therapeutics Developer of cell and gene therapies to treat various diseases | $4M | 14 mo ago | — | Jonathan Naccache Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+12 | — | — |
| 22 | Novacyt A molecular diagnostics company specializing in genomic medicine solutions | $4M | 96 mo ago | 222 | — | WordPressApple iCloud MailMySQL+25 | 133 patents Automated sample prep and digital cytology/histology analysis for cellular diagnostics | — |
| 23 | QUIDDITAS Developer of genome editing-based therapies with genetic recombination technology | $3M | 13 mo ago | — | Francois Cherbonneau Co-Founder & CEO | — | — | — |
| 24 | ScreenCell Developer of circulating tumor cells | $3M | 113 mo ago | 11 | — | — | 32 patents Microfluidic biomarker assays for circulating tumor cell detection and sickle‑cell diagnostics | — |
| 25 | Epigene Labs Developer of drugs through precision oncology | $3M | 46 mo ago | 25 | Akpeli Nordor Co-Founder | WordPressMySQLPHP+22 | — | — |
| 26 | BforCure Developer of a PCR device for pathogen detection | $2M | 36 mo ago | 55 | — | — | 34 patents Integrated microwave sample‑lysis and multiplex real‑time PCR diagnostic platforms | — |
| 27 | Minos Biosciences Developer of a sequencing-based multi-omic analysis device | $2M | 62 mo ago | 11 | Hubert Geisler Co-founder & Head of Microfluidics | — | — | — |
| 28 | En Carta Developer of molecular diagnostic tests for infectious diseases | $2M | 25 mo ago | 3 | Margot Karlikow Co-Founder | — | — | 1 partnership |
| 29 | GreenTropism Provider of software components for mainstream and industrial spectroscopy | $1M | 106 mo ago | 13 | Anthony Boulanger Founder & CEO | — | 31 patents Rapid pathogen detection in biological fluids using surface-enhanced Raman spectroscopy | — |
| 30 | GenoSafe Provider of CRO and consulting company specializing in developing biological products | $1M | 101 mo ago | — | Jean-Francois Col CEO | — | — | — |
| 31 | Millidrop Provider of cell culture machines based on milli fluidics technology for bacteriological research | $1M | 93 mo ago | 5 | — | — | — | — |
| 32 | Brain Vectis Developer of gene therapies for the treatment of Alzheimer's and Huntington's disease | $1M | 117 mo ago | 5 | — | — | — | — |
| 33 | NeoNeuro Provider of aptamer-based molecular diagnostics for Alzheimer's Disease | $363K | 69 mo ago | — | Gregory Penner Founder & President | — | 6 patents Aptamer-based biomarker discovery for early Alzheimer's disease diagnostics | — |
| 34 | Anova Plus Developd diagnostic and decision support tools for agro-industry | $223K | 77 mo ago | — | Marc Masson Founder | — | 11 patents Field diagnostic assays for multi‑resistant fungal pathogens in cereals and human/animal health | — |
| 35 | Plantik Biosciences Developer of plant engineering workflow to create climate-resilient and thermotolerant plants | $100K | 25 mo ago | 6 | Aditya Nayak Co-Founder & CTO | Cart FunctionalitySquarespace CommerceSquarespace+10 | 2 patents Plant genome editing technologies for precise genetic modifications | 1 expansion |
| 36 | Sebia Developer of electrophoresis-based in vitro diagnostics products | — | 41 mo ago | 87 | — | WordPressSentryApple iCloud Mail+24 | 106 patents Patents concentrated in computing, sensing & instrumentation | — |
Top 12 Genomics companies in Ile de France
#1
Public · Paris, Ile de France · founded 2011 · 23 employees$76.6Mraised▾
Public · Paris, Ile de France · founded 2011 · 23 employees
Developer of viral vector-based gene therapies for retinal neurodegenerative diseases. The company develops innovative approaches to prevent retinal degeneration in selected pathological conditions, to restore vision in patients suffering from very low vision or blindness. Its lead product candidates include GS010, an AAV2 containing the human wild-type ND4 gene for the treatment of Leber Hereditary Optic Neuropathy associated with a mutation in the ND4 gene, and GS030 which comprises a gene encoding a photoactivatable channelrhodopsin for the treatment of retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
AI
top 15%Product
top 19%Funding
top 20%Patents
top 33%Moat
top 38%Innovation
top 43%AI: Holds AI/ML patents (G06N-family CPC)
Product: 3 distinct product lines · Company stage: Public
Funding: Raised $76.6M across 9 rounds · 9 rounds over 13 yrs (0.7/yr) · Last round Post IPO (Mar 2026)
Audience (LinkedIn): 10k LinkedIn followers — 5.4% of this cohort's audience
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Mar 2026Post IPO$2M
- Dec 2025Post IPO$3.4M
- Nov 2025Post IPO$2.3M
- Oct 2025Post IPO$4.3M
Investors
Abingworth, Versant Ventures, Index Ventures, Novartis Venture Fund, Fidelity Investments, Jennison
Tech stack
Apache Http ServerGoogle AnalyticsJqueryMediaelement.JsMicrosoft 365Microsoft Advertising
#2
Series B · Paris, Ile de France · founded 2014 · 44 employees$52.3Mraised▾
Series B · Paris, Ile de France · founded 2014 · 44 employees
Developer of in vivo gene editing technology for microbiome modulation. The company offers a platform to edit the microbiome's gene repertoire. This platform aims to address diseases triggered or aggravated by specific bacterial genes. The technology targets the interactions between the microbiome and the host's immune system.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Patents
top 16%Innovation
top 19%Moat
top 29%Funding
top 36%Tech
top 48%Talent
bottom 49%Patents: 199 patents matched (strict assignee match) · 142 filings since 2022 vs 57 in 2017-21 · Latest publication 2026
Innovation: 199 patents (top 13% of patent-holders) · 142 filings since 2022 vs 57 in 2017-21
Moat: Editorial + unicorn rating 7/10 · IP moat: 199 patents · 10 curated direct competitors tracked
Audience (LinkedIn): 16k LinkedIn followers — 8.7% of this cohort's audience
Hiring (LinkedIn): 3 hiring posts in 12 mo (public) · hiring: Research Scientist, Internship
Funding rounds
- May 2025Grant (prize money)$5M
- Nov 2023Series B$30.1M
- Mar 2022Grant (prize money)$55.7K
- Apr 2019Grant (prize money)$3.1M
Founders & team
Investors
Sanofi Ventures, Bpifrance, Khosla Ventures, Seventure Partners, EIC Fund, Europa
Tech stack
Amazon Web ServicesApple Icloud MailBootstrapChart.JsCloudflareCloudflare Browser Insights
#3
Series A · Paris, Ile de France · founded 2020$5Mraised▾
Series A · Paris, Ile de France · founded 2020
Developer of single-cell therapeutics solutions to treat multiple health disorders. The company's proprietary platform uses single-cell RNA and DNA sequencing that helps to analyze disease-causing agents and provides treatment solutions. The company has developed single-cell computational software for the analysis of genomic data.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 4.2% of this cohort's audience
Activity: 1 partnerships · 2 awards · 1 expansions (incl. Guddine Roussy) announced in 12 mo
Funding rounds
- Jul 2025Series A$17.4M
- Sep 2022Series A$5M
Founders & team
Investors
Galion.exe, Invus, Adamed, Sofinnova Investments, Polytechnique Ventures, Kima Ventures
Tech stack
FlywheelGsapMicrosoft 365MysqlOpen GraphOvhcloud
#4
Series C · Paris, Ile de France · founded 2014 · 202 employees$315Mraised▾
Series C · Paris, Ile de France · founded 2014 · 202 employees
DNA script is a developer of a benchtop DNA printer powered by enzymatic technology for nucleic acid syntheis. It is offering a benchtop DNA printer that provides outsourced chemical-based DNA synthesis through enzymatic synthesis technology to synthesize DNA.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 24k LinkedIn followers — 13.1% of this cohort's audience
Funding rounds
- Sep 2023Grant (prize money)$4.3M
- Jan 2022Series C$35M
- Oct 2021Series C$165M
- Sep 2021Grant (prize money)$280K
Founders & team
Investors
Europa, EIC Fund, DARPA, eureKARE, T. Rowe Price, Baillie Gifford
Tech stack
AosBootstrapBugherdCloudflareCloudflare Bot ManagementFancybox
#5
Series A · Paris, Ile de France · founded 2019 · 10 employees$16.4Mraised▾
Series A · Paris, Ile de France · founded 2019 · 10 employees
Provider of AI-based drug discovery and omics analysis tool for researchers. The company has developed tools that are AI-enabled for the process of drug discovery. The tool assists in provided insights for target protein for the drug for an individual patient. The tools use machine learning technology to identify molecular triggers for the drug and target identification. It has features to process biological data, tools for genomic screening, and more.
Fliar Intelligence Index™ 37how this company ranks against its industry peers
AI
top 22%Funding
top 40%Moat
top 45%Patents
top 48%Innovation
top 49%Talent
bottom 49%AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) · Product described with: ai-based, machine learning
Funding: Raised $16.4M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) · Last round Series A (Dec 2024)
Moat: Editorial + unicorn rating 4/10 · IP moat: 4 patents
Audience (LinkedIn): 5k LinkedIn followers — 3.0% of this cohort's audience
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Dec 2024Series A$10.5M
- Oct 2022Series A$5.9M
Founders & team
Investors
YZR Capital, Beiersdorf, Groupe Prunay, Turenne Groupe, Paris Business Angels, Mid Atlantic Bio Angels
#6
Seed · Paris, Ile de France · founded 2024$4Mraised▾
Seed · Paris, Ile de France · founded 2024
Developer of cell and gene therapies to treat various diseases. The company is developing next-generation recombinases ultra-precise and efficient enzymes that surpass CRISPR-Cas9 to revolutionize cell and gene therapies, enabling large-scale production to treat cancer, genetic disorders, and other diseases.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
- Apr 2025Seed$4M
Founders & team
Investors
Kurma Partners, Breega, Kima Ventures, Plug and Play Tech Center
#7
Seed · Montlhery, Ile de France · founded 2021$2.9Mraised▾
Seed · Montlhery, Ile de France · founded 2021
Developer of genome editing-based therapies with genetic recombination technology. It offers CRISPR-based genome editing technology for developing therapeutics for red blood diseases.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 842 LinkedIn followers
Funding rounds
- May 2025Seed$1M
- May 2025Grant (prize money)$1.9M
Founders & team
Investors
iXLife Capital, Wallonia
#8
Series A · Paris, Ile de France · founded 2021 · 10 employees$5.2Mraised▾
Series A · Paris, Ile de France · founded 2021 · 10 employees
Online platform offering bio-digital data storage solutions. The platform is developing a petrol-free DNA synthesis and copy process based on synthetic biology for data storage. It also allows the production of long, bio-sourced, biocompatible, and bio-secure DNA fragments that can be stored as inert polymers for thousands of years without any energy input.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 15k LinkedIn followers — 8.2% of this cohort's audience
Funding rounds
- Dec 2024Series A$18M
- Nov 2022Seed$5.2M
Founders & team
Investors
eureKARE, La French Tech, Paris Business Angels, Crédit Mutuel Innovation, Bpifrance, Next Sequence
Tech stack
AxeptioCloudflareGoogle Font ApiGoogle Hosted LibrariesGoogle WorkspaceGsap
#9
Series B · Paris, Ile de France · founded 2016 · 41 employees$128.1Mraised▾
Series B · Paris, Ile de France · founded 2016 · 41 employees
Developer of drugs using gene therapy to treat retinitis pigmentosa. The company discovers and develops genetic medicine which is used to prevent the degeneration of cones cells in the retina to treat inherited retinal diseases. The company develops a single-injection dosage form for gene therapy.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 3.9% of this cohort's audience
Activity: 2 awards announced in 12 mo
Funding rounds
- Sep 2022Series B$75.5M
- Jul 2021Grant (prize money)$59.4K
- Oct 2020Series A$52.5M
- Aug 2019Grant (prize money)$2.7M
Founders & team
Investors
EIC Fund, EIT Health, Jeito, UPMC Enterprises, Ysios Capital, 4Bio Capital
Tech stack
Animate.CssFlickityFont AwesomeGoogle Font ApiGsapHowler.Js
#10
Series D · Paris, Ile de France · founded 2013 · 75 employees$179.5Mraised▾
Series D · Paris, Ile de France · founded 2013 · 75 employees
Provider of a technology platform for the discovery of antibody-based drugs. The platform combines high throughput, single-cell, functional-based screening of entire B cell (Ab producing cells) populations with next-generation sequencing and rapid DNA synthesis for rare antibody drugs.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 5.5% of this cohort's audience
Funding rounds
- Jun 2021Series D$75M
- Aug 2019Series C$67M
- May 2018Series B$37.5M
- Series A—
Founders & team
Investors
Sequoia Capital, Sherpa Healthcare Partners, Maison Capital, Grand Mount Capital, HKSTP, TIF
Tech stack
Master SliderWordpressMysqlPhpZurb FoundationGravity Forms
#11
Acquired · Villejuif, Ile de France · founded 2013 · 100 employees$53.1Mraised▾
Acquired · Villejuif, Ile de France · founded 2013 · 100 employees
Developer of digital PCR solution for research. The system works on the principle of Crystal Digital PCR in a compact and reliable digital PCR solution with a single consumable. The device is assisted by Crystal Miner software for analyzing the generated data and identifying positive and negative droplets for all 3 fluorescence channels.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 14k LinkedIn followers — 7.5% of this cohort's audience
Funding rounds
- Nov 2021Conventional Debt$22.5M
- Nov 2021Series B$12.7M
- Feb 2020Series B$22.1M
- Nov 2018Series A$18.3M
Founders & team
Investors
Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed Fund, BNP Paribas Developpement, Enlighten Holdings
#12
Series A · Paris, Ile de France · founded 2017 · 44 employees$7.9Mraised▾
Series A · Paris, Ile de France · founded 2017 · 44 employees
Scipio Bioscience is engaged in the development of sample preparation solutions for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular, transcriptomics.
Funding rounds
- 2023Grant (prize money)—
- Feb 2020Series A$6.5M
- Nov 2017Seed$1.4M
Founders & team
Investors
M Ventures, Seventure Partners, Financiere Arbevel, HTGF, Verve Ventures, EIC Fund
Tech stack
WordpressMysqlPhpBootstrapAnimate.CssWp Rocket
Funding & investor landscape
$998.1Mtotal disclosed funding
35companies funded
106disclosed rounds
0rounds last 90 days
Most active investors
Bpifrance9 rounds
Notable founders
Xavier Duportet
Co-Founder & CEO · Eligo Bioscience
Celine Vallot
Co-Founder · One Biosciences
David Schilansky
Co-Founder · One Biosciences
Xavier Godron
Co-founder & CTO · DNA Script
Jonathan Baptista
Co-Founder & CEO · DeepLife
Jonathan Naccache
Co-Founder & CEO · Brink Therapeutics
Harry Kemble
Co-Founder & CTO · Brink Therapeutics
Francois Cherbonneau
Co-Founder & CEO · QUIDDITAS
Aurore Prunevieille
Co-Founder · QUIDDITAS
Erfane Arwani
Co-Founder & CEO · Biomemory
Pierre Crozet
Co-Founder · Biomemory
Jose Sahel
Co-Founder · SparingVision
Prism market signals · France · country-scoped Prism corpus, 1,996,380 docs
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · France
How research on Bioinformatics is moving in France
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,937 France-affiliated papers.
research sentiment over time
200820162030
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and softening — the enthusiastic (strongly-positive) share moved 48% → 44% across 2008–2030.
top research entities
- Centre National de la Recherche Scientifique581
- Inserm393
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement130
- Assistance Publique – Hôpitaux de Paris112
- European Molecular Biology Laboratory87
leading researchers
Engelhorn, Julia · Valentin Sorin · Damian Szklarczyk · Andrew Mc Carthy · Maulana M. Naji · Lars Juhl Jensen · Peer Bork · F. Besnard
▲
Breakthroughs770 · 40%
40%→40% share
▲1.0× share momentum0 median citations87% since 2021mostly methods-led
Breakthroughs are cooling (40%→40% of field), led by Genome.
rising sub-themes (early→recent)
- Genome15→94
- Gene20→91
- Transcriptome2→53
- Chromatin2→28
- Identification (biology)2→27
Newly emergingDisease 0→30 · Workflow 0→24 · In silico 0→20
Landmark Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · 97,164 cites
◆
Advancements532 · 27%
▲ 19%→28% share
▲1.5× share momentum0 median citations89% since 2021mostly empirical
Advancements are rising (19%→28% of field), led by Gene.
rising sub-themes (early→recent)
- Gene4→56
- Transcriptome3→39
- Genome5→24
- Biomarker1→17
- In silico1→16
Newly emergingDisease 0→39 · Immune system 0→23 · Cancer 0→19
Landmark Differential expression analysis for sequence count data · 16,273 cites
▼
Concerns285 · 15%
▼ 21%→14% share
▼0.7× share momentum0 median citations83% since 2021mostly reviews
Concerns are cooling (21%→14% of field), led by Disease.
rising sub-themes (early→recent)
- Disease3→34
- Gene1→19
- Cancer2→17
- Clinical trial2→16
- Immune system2→14
Newly emergingTranscriptome 0→12 · Adverse effect 0→10 · MEDLINE 0→9
Landmark A standardised staticin vitrodigestion method suitable for food – an international consensus · 5,317 cites
RESEARCH HOTSPOTS · France
Where bioinformatics is researched across France
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Paris554 · +0.49
Marseille75 · +0.51
Lyon69 · +0.49
Grenoble50 · +0.48
Toulouse45 · +0.41
Strasbourg38 · +0.51
PATENT SIGNAL · France
Who's filing bioinformatics patents in France
France bioinformatics patent filing is steady — 2 filings from 4 assignees (2024–2025), led by UNIV Paris CITE, Centre NAT RECH Scient, Ecole NAT Superieure DE Chimie P; annual filings 1→1.
2 filings4 assigneespeak 1/yr2024–2025
filing momentum (YoY 2024–2025)
top patent filers
- UNIV Paris CITE2
- Centre NAT RECH Scient2
- Ecole NAT Superieure DE Chimie P1
- Ecole NAT Superieure DE Chimie D1
Common questions
How many Genomics companies are there in Ile de France, France?
Radar tracks 71 indexable Genomics companies headquartered in Ile de France, France that meet our profile-completeness bar.
What is the total funding raised by Genomics companies in Ile de France, France?
The Genomics companies in Ile de France, France on this list have raised a combined $998.1M in disclosed equity funding across 35 funded companies.
Which is the highest-funded Genomics company in Ile de France, France?
DNA Script is the highest-funded Genomics company in Ile de France, France, with $315M in disclosed equity funding.
How many Genomics companies in Ile de France, France are funded?
35 of the 71 Genomics companies in Ile de France, France on this list have disclosed at least one equity funding round.
How many Genomics unicorns are there in Ile de France, France?
None of the Genomics companies in Ile de France, France on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Ile de France, France Genomics companies?
The most active investors in Ile de France, France Genomics companies on this list include Europa, Bpifrance, Kurma Partners, EIC Fund, Idinvest Partners.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.